Vyvanse Generics On the Way
As the U.S. patent for Vyvanse expired August 2023, the FDA cleared 14 manufacturers to produce Vyvanse generics. It might take several months for a significant number of consumers to access these Vyvanse generics.
All About Adult ADHD — Especially Relationships
As the U.S. patent for Vyvanse expired August 2023, the FDA cleared 14 manufacturers to produce Vyvanse generics. It might take several months for a significant number of consumers to access these Vyvanse generics.
Update 12/20/22: For years, consumers have been able to get the brand Concerta sold as a generic — that is, an “authorized generic.” That has ended. With the introduction since 2016 of about 20 cheap
In case you missed it, there is a longer-lasting version of Adderall, called Mydayis. Many people report frustration with the current Adderall shortage. I suggest that a trial of Mydayis would be worth a shot—and
This post contains my comprehensive report on the Concerta generics downgraded by the FDA in 2016. It explains many facts consumers need to understand about generics, consumer rights/options, and more. It was thanks to ADHD
These first-person stories from generic Concerta users recount the dramatic and adverse changes they experienced—often not knowing why . This started around 2015. Typically, those associating their devolved functioning with the different-looking “Concerta” pill
The best news! The FDA announced today that the two approved generic versions of Concerta manufactured by Mallinckrodt Pharmaceuticals and Kudco have been downgraded. It’s horrifying that so many people have already been adversely affected,
To all ADHD Roller Coaster blog readers who took the time to complete the FDA’s complaint form after experiencing adverse effects from the new Concerta generics: Good job! You have helped to place these generics